Volume 14, Number 6—June 2008
Perspective
Major Issues and Challenges of Influenza Pandemic Preparedness in Developing Countries
Hitoshi Oshitani*
, Taro Kamigaki*, and Akira Suzuki*
, Taro Kamigaki*, and Akira Suzuki*
Table 1
Cost of purchasing oseltamivir to cover 25% of population with regard to total health expenditure in countries with different economic status*
| Category of country | Average GNP, per capita† | Average annual health expenditure, per capita† | Cost of 1 treatment course of oseltamivir, % annual health expenditure |
|---|---|---|---|
| High income | 30,168 | 3,376 | 0.11 |
| Upper middle income | 4,310 | 280 | 1.34 |
| Lower middle income | 1,364 | 77 | 4.87 |
| Low income | 753 | 29 | 12.93 |
*Data obtained from World Health Organization website (www.who.int/nha). GNP, gross national product.
†In US$.
Page created: July 09, 2010
Page updated: July 09, 2010
Page reviewed: July 09, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.